Endo Hirsutism Either Approach Mild No Endocrine

---
name: endo-hirsutism-either-approach-mild-no-endocrine
description: For a premenopausal woman presenting with mild hirsutism (Ferriman–Gallwey score 8–15) and no clinical evidence of an endocrine disorder (eumenorrheic menses, absence of hyperandrogenic signs), the clinician should consider either pharmacologic therapy or direct hair removal as initial management options. Choose pharmacologic therapy (e.g., combined oral contraceptive) or direct hair removal (laser/photoepilation or electrolysis) based on patient preference, contraceptive needs, and hair characteristics.
---

# Choose either pharmacologic therapy or direct hair removal for mild hirsutism without endocrine disorder

## STEP 1 — Gather Information
Collect menstrual history (eumenorrheic vs irregular), assess hirsutism using Ferriman–Gallwey score (nine areas: upper lip, chin, chest, upper back, lower back, upper abdomen, lower abdomen, thigh, upper arm), screen for hyperandrogenic signs (acne, alopecia, voice deepening, clitoromegaly, increased muscle mass), review medications (exogenous androgens, valproic acid), and note patient hair color and treatment goals.  
**Action:** Calculate the Ferriman–Gallwey score and determine if mild (8–15) with no endocrine signs.

## STEP 2 — Rule In / Rule Out
Is there clinical evidence of an endocrine disorder (menstrual irregularity <21 days or >35 days, infertility, acanthosis nigricans, BMI ≥30 kg/m², or virilization signs)?  
- **Yes:** Rule out idiopathic hirsutism and proceed to endocrine workup (measure serum total/free testosterone, 17‑hydroxyprogesterone).  
- **No:** Proceed to step 3.

## STEP 3 — Classify or Stratify
Classify hirsutism severity: mild (FG 8–15) vs moderate/severe (>15).  
- **Mild hirsutism without endocrine disorder:** Proceed to step 4.  
- **Moderate/severe hirsutism:** Initiate pharmacologic therapy first.

## STEP 4 — Decide
Choose either pharmacologic therapy (combined oral contraceptive ± antiandrogen after 6 months if suboptimal) or direct hair removal (laser/photoepilation for pigmented brown/black hair, electrolysis for blond/white hair) based on patient preference, contraceptive needs, hair characteristics, and cost.

## Clinical Guardrails / Mimics / Pitfalls
Do not use antiandrogen monotherapy without reliable contraception due to teratogenic risk; avoid insulin‑lowering drugs (metformin) for hirsutism alone; do not rely on topical antiandrogens; warn of paradoxical hypertrichosis with photoepilation in Mediterranean/Middle Eastern women with facial hirsutism; do not delay treatment if patient‑important hirsutism persists despite cosmetic measures.

## Concrete Clinical Example
A 24‑year‑old eumenorrheic woman presents with FG score 12 (upper lip and chin), regular menses, no acne/alopecia, desires facial hair reduction. She has no endocrine signs. After counseling, she chooses a course of laser photoepilation for her dark facial hair.

**Source:** Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2018, DOI:10.1210/jc.2018-00241  
> **TODO:** consider adding scripts/calc.py for the endo-hirsutism-either-approach-mild-no-endocrine calculator